Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Osteoporos Int

Search In Journal Title:

Abbravation: Osteoporosis International

Search In Journal Abbravation:

Publisher

Springer-Verlag

Search In Publisher:

DOI

10.1016/0735-1097(91)92084-Y

Search In DOI:

ISSN

1433-2965

Search In ISSN:
Search In Title Of Papers:

Development and application of a Japanese model of

Authors: S Fujiwara T Nakamura H Orimo T Hosoi I Gorai A Oden H Johansson J A Kanis
Publish Date: 2008/02/22
Volume: 19, Issue: 4, Pages: 429-435
PDF Link

Abstract

The present study estimated the 10year probability using the Japanese version of WHO fracture risk assessment tool FRAX™ in order to determine fracture probabilities that correspond to intervention thresholds currently used in Japan and to resolve some issues for its use in JapanThe objective of the present study was to evaluate a Japanese version of the WHO fracture risk assessment FRAX™ tool to compute 10year probabilities of osteoporotic fracture in Japanese men and women Since lumbar spine bone mineral density BMD is used preferentially as a site for assessment and densitometers use Japanese reference data a second aim was to investigate the suitability and impact of this practice in JapanFracture probabilities were computed from published data on the fracture and death hazards in Japan Probabilities took account of age sex the presence of clinical risk factors and femoral neck BMD Fracture probabilities were determined that were equivalent to intervention thresholds currently used in Japan The difference between Tscores derived from international reference data and that using Japanesespecific normal ranges was estimated from published sources The gradient of risk of BMD for fracture in Japan was compared to that for BMD at the lumbar spine in the Hiroshima cohortThe 10year probabilities of a major osteoporosisrelated fracture that corresponded to current intervention thresholds ranged from approximately 5 at the age of 50 years to more than 20 at the age of 80 years The use of femoral neck BMD predicts fracture as well as or better than BMD tests at the lumbar spine There were small differences in Tscores between those used for the model and those derived from a Japanese reference populationThe FRAX™ tool has been used to determine possible thresholds for therapeutic intervention based on equivalence of risk with current guidelines The approach will need to be supported by appropriate health economic analyses Femoral neck BMD is suitable for the prediction of fracture risk among Japanese However when applying the FRAX™ model to Japan Tscores and Zscores should be converted to those derived from the international referenceFractures related to osteoporosis have become a major health and economic burden in Asian countries just as they have in North America and Europe An estimated 117900 cases of hip fracture occurred in 2002 1 and the incidence in Japan has increased in the past 10 years 1 2 Asia will be expected to have the highest absolute increase in fracture number because it has the largest population Early detection of individuals with high fracture risk using clinical risk factors would have a substantial impact on reducing the burden of fractures in AsiaA series of metaanalyses on prospective populationbased cohorts has identified a number of clinical risk factors that contribute to fracture risk independently of BMD at the femoral neck 3 The integration of these risks would therefore enhance the predictive value of BMD 4 The risk factors comprise age sex bone mineral density body mass index BMI longterm use of glucocorticoids parental history of hip fracture history of fragility fracture smoking alcohol consumption 3 or more units/day and secondary osteoporosis such as rheumatoid arthritis A WHO scientific group has proposed that the 10year probability for fracture is used to express fracture risk for clinical assessment 5 and to determine intervention thresholds 3 The aim of this study was to create a fracture probability model based on the methodology of the WHO risk assessment tool FRAX™ 6 calibrated to the epidemiology of JapanIn addition several problems need to be resolved before the FRAX™ model is applied to Japan First the FRAX™ tool inputs femoral neck BMD and the Zscore or Tscore is based on the NHANES III reference data base In Japan BMD at the lumbar spine is widely used clinically because the physical size of Japanese people is smaller than that of Western people giving rise to a view based on little evidence that the reproducibility of measurements at the femoral neck BMD would be poorer than that at the lumbar spine Furthermore data on the young adult mean YAM and the mean at each age are installed in the DXA systems in Japan and programmed to calculate T and Zscores from Japanese reference data In addition the Japanese Society for Bone and Mineral Research 7 8 provide recommendations for the diagnosis of osteoporosis and intervention based on YAM and these are widely used in clinical practice


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Development of an electronic medical record based intervention to improve medical care of osteoporosis
  2. Morbidity following lower extremity fractures in men with spinal cord injury
  3. DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass
  4. Effects of 25-hydroxyvitamin D level and its change on parathyroid hormone in premenopausal Chinese women
  5. Thalassemia bone disease: the association between nephrolithiasis, bone mineral density and fractures
  6. Evaluation of three risk assessment tools in discriminating fracture status among Chinese patients undergoing hemodialysis
  7. Oral bisphosphonates and risk of ischemic stroke: a case–control study
  8. The association between serum osteocalcin levels and metabolic syndrome in Koreans
  9. Place of residence and risk of fracture in older people: a population-based study of over 65-year-olds in Cardiff
  10. Fracture risk and adjuvant hormonal therapy among a population-based cohort of older female breast cancer patients
  11. Cost-utility of long-term strontium ranelate treatment for postmenopausal osteoporotic women
  12. Effects of therapeutic exercise for persons with osteoporotic vertebral fractures: a systematic review
  13. Genetic analysis of serum osteocalcin and bone mineral in multigenerational Afro-Caribbean families
  14. Effect of hospitalist consultation on treatment of osteoporosis in hip fracture patients
  15. Declining incidence of low-trauma knee fractures in elderly women: nationwide statistics in Finland between 1970 and 2006
  16. Changing health behaviors with social marketing
  17. Selective protein depletion impairs bone growth and causes liver fatty infiltration in female rats: prevention by Spirulina alga
  18. The vertebral fracture cascade in osteoporosis: a review of aetiopathogenesis
  19. Clinical performance of osteoporosis risk assessment tools in women aged 67 years and older
  20. Osteoporosis and venous thromboembolism: a retrospective cohort study in the UK General Practice Research Database
  21. One year outcomes and costs following a vertebral fracture
  22. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study
  23. Classification of women with and without hip fracture based on quantitative computed tomography and finite element analysis
  24. Influence of age and sex steroids on bone density and geometry in middle-aged and elderly European men
  25. The relationship of vitamin D status to bone mineral density in an Italian population of postmenopausal women
  26. Effects of a combined alendronate and calcitriol agent (Maxmarvil®) on bone metabolism in Korean postmenopausal women: a multicenter, double-blind, randomized, placebo-controlled study
  27. Tracking of size-adjusted bone mineral content and bone area in boys and girls from 10 to 17 years of age
  28. Vertebral Scheuermann’s disease in Europe: prevalence, geographic variation and radiological correlates in men and women aged 50 and over
  29. Age-related hyperkyphosis, independent of spinal osteoporosis, is associated with impaired mobility in older community-dwelling women
  30. Performance of COLIA1 Polymorphism and Bone Turnover Markers to Identify Postmenopausal Women with Prevalent Vertebral Fractures
  31. Economic burden of privately insured non-vertebral fracture patients with osteoporosis over a 2-year period in the US
  32. Vitamin D status in men with psoriatic arthritis: a case-control study
  33. Long-term treatment of osteoporotic women with bisphosphonates does not impair the response to subsequently administered intravenous pamidronate
  34. Treatment satisfaction and persistence among postmenopausal women on osteoporosis medications: 12-month results from POSSIBLE US™
  35. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture
  36. De novo autoimmune hepatitis associated with PTH(1–34) and PTH(1–84) administration for severe osteoporosis in a liver transplant patient
  37. Basic fibroblast growth factor has rapid bone anabolic effects in ovariectomized rats
  38. Precision of 18 F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism
  39. RETRACTED ARTICLE: Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study
  40. Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study
  41. Quantitative ultrasound and fracture risk prediction in non-osteoporotic men and women as defined by WHO criteria
  42. Treatment with acetaminophen/paracetamol or ibuprofen alleviates post-dose symptoms related to intravenous infusion with zoledronic acid 5 mg
  43. Serum sclerostin: the missing link in the bone-vessel cross-talk in hemodialysis patients?
  44. Lack of response to teriparatide therapy for bisphosphonate-associated osteonecrosis of the jaw: reply to Subramanian and Quek
  45. The Presence and Severity of Vertebral Fractures is Associated with the Presence of Esophageal Hiatal Hernia in Postmenopausal Women
  46. Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
  47. Influence of fall related factors and bone strength on fracture risk in the frail elderly
  48. Discriminative value of FRAX for fracture prediction in a cohort of Chinese postmenopausal women
  49. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism
  50. Stroke in relation to use of raloxifene and other drugs against osteoporosis
  51. Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women
  52. The relationship between low bone mass and metabolic syndrome in Korean women
  53. Effect of high-dose cholecalciferol (vitamin D 3 ) on bone and body composition in children and young adults with HIV infection: a randomized, double-blind, placebo-controlled trial
  54. Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence
  55. Treatment of osteoporosis after alendronate or risedronate
  56. Vertebral anti-fracture efficacy of strontium ranelate according to pre-treatment bone turnover
  57. Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women
  58. Bone mass following physical activity in young years: a mean 39-year prospective controlled study in men
  59. Fracture Reduction Affects Medicare Economics (FRAME): Impact of increased osteoporosis diagnosis and treatment
  60. Low skeletal muscle mass associates with low femoral neck strength, especially in older Korean women: the Fourth Korea National Health and Nutrition Examination Survey (KNHANES IV)
  61. Age-related differences in the activity of arterial mineral deposition and regional bone metabolism: a 18 F-sodium fluoride positron emission tomography study
  62. Copper deficit as a potential pathogenic factor of reduced bone mineral density and severe tooth wear
  63. Has Choosing Wisely® affected rates of dual-energy X-ray absorptiometry use?
  64. RisedronatE and ALendronate Intervention over Three Years (REALITY): minimal differences in fracture risk reduction
  65. Sensitivity and specificity of radiographic characteristics in atypical femoral fractures
  66. The interaction of ethnicity and chronic disease as risk factors for osteoporotic fractures: a comparison in Canadian Aboriginals and non-Aboriginals
  67. Association between osteocalcin and glucose metabolism: a meta-analysis
  68. Decreased serum sclerostin levels in patients with primary hyperparathyroidism: a cross-sectional and a longitudinal study
  69. Targeted education improves the very low recognition of vertebral fractures and osteoporosis management by general internists
  70. Results of indirect and mixed treatment comparison of fracture efficacy for osteoporosis treatments: a meta-analysis
  71. Evaluation of panoramic radiomorphometric indices related to low bone density in sickle cell disease
  72. Morphological changes of injected calcium phosphate cement in osteoporotic compressed vertebral bodies
  73. Both resistance and agility training reduce back pain and improve health-related quality of life in older women with low bone mass
  74. Homocysteine and fracture risk in postmenopausal women: the OFELY study
  75. Excess mortality following hip fracture: a systematic epidemiological review
  76. A double-blind, randomized, Phase III, multicenter study in 358 pediatric subjects receiving isotretinoin therapy demonstrates no effect on pediatric bone mineral density
  77. Weight loss and distal forearm fractures in postmenopausal women
  78. Implementation of osteoporosis guidelines: a survey of five large fracture liaison services in the Netherlands
  79. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  80. Systemic treatment with strontium ranelate promotes tibial fracture healing in ovariectomized rats
  81. BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial

Search Result: